Hybio Pharmaceutical (SHE:300199) will sell glucagon-like peptide (GLP-1) raw materials to an unnamed customer for 180 million yuan, according to a Friday disclosure to the Shenzhen bourse.
GLP-1 helps regulate blood sugar and appetite and is used in slimming products.
The amount is equivalent to about 31% of the entire audited revenue of the listed company in 2024, according to the filing.